The Effects of Livercare Tablet [Combination of Milk Thistle, Dandelion, Barberry, Tumeric (Curcumin), and Artichoke] in Prevention of Anti-Tuberculosis Drugs-Induced Hepatotoxicity: A Randomized Controlled Clinical Trial

Document Type : Original Article (s)

Authors

1 Assistant Professor, Department of Infectious and Tropical Diseases, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Resident, Department of Infectious and Tropical Diseases, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Professor, Nosocomial Infections Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

4 Professor, Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

5 Associate Professor, Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences AND Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Hepatotoxicity is a serious complication of anti-tuberculosis drugs, and so far, no ideal preventive measure has been suggested for it.. The aim of this study was determining the effects of Livercare tablet [combination of milk thistle, dandelion, barberry, turmeric (curcumin), and artichoke] in the prevention of hepatotoxicity induced by anti-tuberculosis drugs.Methods: In a randomized controlled clinical trial study, 44 patients with pulmonary tuberculosis were divided into two groups of 22 patients. In the first group (intervention group), Livercare tablets made by HealthAid Company were prescribed twice a day for 2 weeks at the same time with the start of anti-tuberculosis drugs. In the second group (control group), only standard anti-tuberculosis treatment was prescribed. The incidence of hepatotoxicity was determined and compared between the two groups.Findings: Examination of liver enzyme levels during two weeks from the start of anti-tuberculosis treatment showed that 7 patients (15.9%) had hepatotoxicity, of which 6 (27.3%) were in the control group and 1 (4.5%) in the intervention group. The incidence of hepatotoxicity was significantly lower in the intervention group (P = 0.039).Conclusion: Concomitant use of the herbal drug Livecare seems to reduce the hepatotoxicity of anti-tuberculosis drugs significantly.

Keywords

References

  1. Tostmann A, Boeree MJ, Aarnoutse RE, de Lange WC, van der Ven AJ, Dekhuijzen R. Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review. J Gastroenterol Hepatol 2008; 23(2): 192-202.
  2. Possuelo LG, Castelan JA, de Brito TC, Ribeiro AW, Cafrune PI, Picon PD, et al. Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil. Eur J Clin Pharmacol 2008; 64(7): 673-81.
  3. Khalili H, Dashti-Khavidaki S, Rasoolinejad M, Rezaie L, Etminani M. Anti-tuberculosis drugs related hepatotoxicity; incidence, risk factors, pattern of changes in liver enzymes and outcome. DARU J Pharm Sci 2015; 17(3): 163-7.
  4. Baniasadi S, Eftekhari P, Tabarsi P, Fahimi F, Raoufy MR, Masjedi MR, et al. Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity. Eur J Gastroenterol Hepatol 2010; 22(10): 1235-8.
  5. Sharma SK, Balamurugan A, Saha PK, Pandey RM, Mehra NK. Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. Am J Respir Crit Care Med 2002; 166(7): 916-9.
  6. Liu Q, Garner P, Wang Y, Huang B, Smith H. Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: Systematic review of ingredients and evaluation studies. BMC Public Health 2008; 8: 365.
  7. Flora K, Hahn M, Rosen H, Benner K. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol 1998; 93(2): 139-43.
  8. Kumar A. A review on hepatoprotective herbal drugs. Int J Res Pharm Chem 2012; 2(1): 96-102.
  9. Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev 2009; 14(3): 226-46.
  10. Fallah Huseini H, Mahmpudabady A, Ziai S, Mehrazma M, Alavian S, Kianbakht S, et al. The effects of taraxacum officinale l. and berberis vulgaris l. root extracts on carbon tetrachloride induced liver toxicity in rats. J Med Plants 2010; 9(6): 45-52.
  11. Speroni E, Cervellati R, Govoni P, Guizzardi S, Renzulli C, Guerra MC. Efficacy of different Cynara scolymus preparations on liver complaints. J Ethnopharmacol 2003; 86(2-3): 203-11.
  12. Fallah Huseini H, Zareei Mahmoudabady A, Ziai S, Mehrazma M, Alavian S, Mehdizadeh M, et al. the effects of Cynara scolymus L. Leaf and Cichorium intybus L. root extracts on carbon tetrachloride induced liver toxicity in rats. J Med Plants 2011; 10(37): 33-40.
  13. Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 2008; 22(8): 999-1012.
  14. Eminzade S, Uraz F, Izzettin FV. Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals. Nutr Metab (Lond) 2008; 5: 18.
  15. Sheikuduman MS, Chetty C, Ramkanth DS, Rajan VST, Kumar K, Karunakaran G. Hepatoprotective Herbs- A Review. Int J Res Pharm Sci 2010; 1(1): 1-5.
  16. Shaker E, Mahmoud H, Mnaa S. Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage. Food Chem Toxicol 2010; 48(3): 803-6.
  17. El-Ansary AK, Ahmed SA, Aly SA. Antischistosomal and liver protective effects of Curcuma longa extract in Schistosoma mansoni infected mice. Indian J Exp Biol 2007; 45(9): 791-801.
  18. Heidarian E, Rafieian-Kopaei M. Protective effect of artichoke (Cynara scolymus) leaf extract against lead toxicity in rat. Pharm Biol 2013; 51(9): 1104-9.
  19. Ahmad D, Gulfraz M, Ahmad MS, Nazir H, Gul H, Asif S. Protective action of Taraxacum officinale on CCl4 induced hepatotoxicity in rats. Afr J Pharm Pharmacol 2014; 8(30): 775-80.
  20. You Y, Yoo S, Yoon HG, Park J, Lee YH, Kim S, et al. In vitro and in vivo hepatoprotective effects of the aqueous extract from Taraxacum officinale (dandelion) root against alcohol-induced oxidative stress. Food Chem Toxicol 2010; 48(6): 1632-7.
  21. Hermenean A, Popescu C, Ardelean A, Stan M, Hadaruga N, Mihali CV, et al. Hepatoprotective effects of Berberis vulgaris L. extract/beta cyclodextrin on carbon tetrachloride-induced acute toxicity in mice. Int J Mol Sci 2012; 13(7): 9014-34.
  22. Fallah Huseini H, Zaree Mahmoudabady A, Naghdi Badi H, Alavian S, Mohammadi Savadroodbari R, Mehdizadeh M. The protective effect of medicinal herbs extracts including Cynara scolymus L., Cichorium intybus L. Taraxacum officinal L. and Berberis vulgaris L. in single and in combination form in CCl4 induced rat liver toxicity. J Med Plants 2012; 11(41): 78-85.
  23. Mulrow C, Lawrence V, Jacobs B, Dennehy C, Sapp J, Ramirez G, et al. Milk thistle: Effects on liver disease and cirrhosis and clinical adverse effects. Evid Rep Technol Assess (Summ) 2000; (21): 1-3.
  24. Zhang J, Kang MJ, Kim MJ, Kim ME, Song JH, Lee YM, et al. Pancreatic lipase inhibitory activity of taraxacum officinale in vitro and in vivo. Nutr Res Pract 2008; 2(4): 200-3.
Journal of Isfahan Medical School
Volume 38, Issue 597 - Serial Number 597
September and October 2021
Pages 804-810

Files

History

  • Receive Date: 06 August 2020
  • Revise Date: 02 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics